Bravman v. Baxter Healthcare Corp.

Decision Date21 January 1993
Docket NumberD,No. 564,564
Parties, Prod.Liab.Rep. (CCH) P 13,396 Aaron BRAVMAN; Muriel Bravman, Plaintiffs-Appellants, v. BAXTER HEALTHCARE CORPORATION, Defendant-Appellee. ocket 92-7645.
CourtU.S. Court of Appeals — Second Circuit

Joshua Paul, New York City (J. Christopher Jensen, Cowan, Liebowitz & Latman, P.C., of counsel), for plaintiffs-appellants.

Lee Davis Thames, Jackson, MS (Butler, Snow, O'Mara, Stevens & Cannada, Daniel J. Thomasch, Donovan Leisure Newton & Irvine, New York City, Marla Persky, Baxter Intern. Inc., Deerfield, IL, of counsel), for defendant-appellee.

Before OAKES and WINTER, Circuit Judges, and PRESKA, * District Judge.

OAKES, Circuit Judge:

Aaron Bravman ("Bravman") and his wife, Muriel Bravman, appeal from a judgment of the United States District Court for the Southern District of New York, Robert W. Sweet, Judge, granting Baxter Healthcare Corporation ("Baxter") summary judgment and dismissing Bravman's amended complaint in a diversity case. The district court determined as a matter of law that Bravman had suffered no physical harm from the implant of a noisy artificial heart valve manufactured by Baxter and did not have a cause of action for the noise and ensuing nervousness and sleeplessness nor for the fear of heart valve failure that the noise engendered. For the reasons set forth below, we affirm in part, reverse in part, and remand with directions. We hold that Bravman does not have a claim for relief under a product or design defect theory of liability. We hold, however, that Bravman is entitled to a jury determination whether the noise emitted by the heart valve caused a cognizable injury and whether Baxter violated a duty to warn Bravman's doctor of the potential noise.

BACKGROUND

On April 5, 1988, Bravman, a Pennsylvania resident, underwent surgery at New York University Hospital to replace his natural mitral heart valve with an artificial Edwards-Duromedics Heart Valve made by Baxter, an Illinois corporation. Bravman's surgery was made necessary by the serious deterioration of his natural heart valve. Dr. Frank Spencer of New York University Hospital performed the surgery. Bravman met once with Dr. Spencer before his operation. At this meeting, Dr. Spencer recommended that Bravman use a mechanical valve rather than a porcine valve, made from natural pig tissue, because of the mechanical valve's greater longevity. However, Dr. Spencer did not discuss with Bravman the variety of mechanical valves available nor did he warn Bravman about the noise associated with the Edwards-Duromedics valve.

Bravman's surgery was successful and his artificial valve continues properly to control the flow of blood into his heart. Nonetheless, Bravman complains of a complication--his valve makes a loud and disruptive noise. Although everyone concedes that all mechanical valves make some noise, Bravman asserts, and is supported in his assertions, that his Edwards-Duromedics valve makes an unacceptable amount of noise. In fact, Bravman contends that, in a quiet environment, his heart valve can be heard from a distance of thirty feet. As a consequence of the valve noise, Bravman claims that he cannot sleep, that he is despondent, and that he was obliged to take an early retirement. Bravman states he has even explored the possibility of undergoing additional surgery to replace the valve to eliminate the noise.

Bravman raised four claims for relief before the district court: breach of express warranty, breach of implied warranty, negligence, and strict product liability. After On appeal, Bravman raises three issues: first, he contends that the district court erred in concluding as a matter of law that the heart valve noise caused him no physical harm, and, therefore, that he has a valid failure-to-warn claim against Baxter; second, he claims that the district court erred in finding that there was no legally cognizable product defect in his Edwards-Duromedics heart valve; and third, he argues that the district court should have allowed a jury to determine whether a design defect existed in light of evidence that alternative valve designs did not create the same level of noise as the Edwards-Duromedics heart valve. We find that the determination whether Bravman sustained a physical injury is a disputed question of fact that should not have been resolved on summary judgment; given the disputed evidence in the record on the question of Baxter's awareness of the noise level, the excessiveness of the noise, and the availability of other mechanical valves with similar functionality and operation at a lower noise level, Bravman's failure to warn claim is viable. The district court, however, correctly determined that as a matter of law Bravman could not recover under either a product defect or design defect theory of liability.

                discovery was closed, Baxter filed a motion for summary judgment, requesting that Bravman's complaint be dismissed with prejudice.   The district court granted the motion on the basis that Mr. Bravman's fear that his mechanical heart valve was going to fail was legally insufficient to support a claim that he was injured and that the excessive heart valve sounds Bravman had experienced since his operation did not support a legally cognizable product defect claim under New York law.  Bravman v. Baxter Healthcare Corp., 794 F.Supp. 96 (S.D.N.Y.1992)
                
DISCUSSION

We begin first with Bravman's claim that Baxter had a duty to warn him that the Edwards-Duromedics heart valve produced excessive noise and that the company violated its duty to warn the relevant medical community about this noise. As the manufacturer of the heart valve, Baxter was obliged "to warn of all potential dangers which it knew, or in the exercise of reasonable care should have known, to exist." Lindsay v. Ortho Pharmaceutical Corp., 637 F.2d 87, 91 (2d Cir.1980).

Evidence in the record shows that Baxter knew that its Edwards-Duromedics valve tended to be noisy and that the noise generated concern among doctors and complaints among patients. In response, Baxter argues that all mechanical valves necessarily make noise and that the noise actually serves an important diagnostic role by enabling cardiologists to monitor the valve sounds and determine whether the valves are functioning properly. This argument, however, does not rebut the complaint of excessive noise. In particular, Bravman points to two types of noise problems of which Baxter was aware when Bravman received the Edwards-Duromedics valve.

First, there is evidence that at the time of Bravman's surgery Baxter knew that the Edwards-Duromedics valve made more noise than some other valves that were available on the market at the time of Bravman's surgery. For example, Baxter had received information from the German Heart Center that the Duromedics valve created more noise than did a rival valve. 1 The record also includes some evidence that cardiologists familiar with the Edwards-Duromedics valve told Baxter that patients complained about noise from the valve. In 1987, Baxter sponsored a symposium on the Edwards-Duromedics valve at which 22 cardiologists from around the world discussed the valve. At the symposium, at least two cardiologists presented information concerning noise problems with the Edwards-Duromedics valve that Bravman also claims that Baxter knew of a second, apparently infrequent, but more severe noise problem: that the Edwards-Duromedics valve creates extraordinary noise in some patients. For example, there is a suggestion in the record that one patient who had received an Edwards-Duromedics valve attempted to commit suicide because his valve noises were disconcertingly loud--the valve noises could be heard, in a quiet room, from as far as twenty feet.

                doctors had observed in the hospitals where they worked.   Both cardiologists suggested that prospective users of the Edwards-Duromedics heart valve should be warned about these potential problems
                

The district court found that Bravman did not present a legally cognizable failure to warn claim despite these allegations. Although there is no dispute that Baxter had at least some information concerning potential noise problems with the Edwards-Duromedics valve, the court determined that the "tonitruous jangle" of the valve did not inflict any physical harm upon Bravman and that there was no evidence that the failure to warn placed Bravman in any physical danger. In support of its findings, the district court cited another failure to warn case, Gerardi v. Nuclear Utility Services, Inc., 149 Misc.2d 657, 660, 566 N.Y.S.2d 1002, 1004-05 (Sup.Ct.West.Co.1991), in which a New York court allowed a plaintiff who had not suffered a physical injury to recover for emotional harm only because there was a real danger to the plaintiff's physical safety.

We do not think that the question whether Bravman has suffered a physical harm can be resolved as a matter of law. Unlike the purely psychological terror suffered by the protagonist in Edgar Allan Poe's "The Tell-Tale Heart," 2 Bravman's complaint, that his artificial heart valve creates excessive noise that prevents him from sleeping, among other things, is objectively verifiable. While Bravman's claim is unusual, it is by no means nonsensical. At some level, noise can constitute a cognizable harm. 3 If Baxter suggests that even if Bravman has a cognizable injury, the evidence precludes a finding that the failure to warn proximately caused this alleged injury. Baxter argues that its duty to warn, if any, was to give information to Dr. Spencer as a "learned intermediary," and that while it had not warned Dr. Spencer, Dr. Spencer testified that he would not have warned Bravman even if he had known about the noise problems.

                for example, Bravman's heart valve was as loud as a lawn mower, and he (or his surgeon) had been given no warning to this effect, we would expect general agreement
...

To continue reading

Request your trial
38 cases
  • Valente v. Textron, Inc.
    • United States
    • U.S. District Court — Eastern District of New York
    • March 18, 2013
    ...(citing Liriano v. Hobart Corp., 92 N.Y.2d 232, 237, 677 N.Y.S.2d 764, 700 N.E.2d 303 (1998)); see also Bravman v. Baxter Healthcare Corp., 984 F.2d 71, 75 (2d Cir.1993) (“A plaintiff proceeding under a failure-to-warn theory in New York must demonstrate that the failure to warn adequately ......
  • In re Bridgestone/Firestone, Inc. Tires Products
    • United States
    • U.S. District Court — Southern District of Indiana
    • July 27, 2001
    ...of action for a faulty heart valve until the valve actually fails and causes a physical harm."), aff'd in part and rev'd in part, 984 F.2d 71 (2d Cir.1993); Pfizer, Inc. v. Farsian, 682 So.2d 405, 407 (Ala.1996) ("Alabama courts have never allowed a recovery based on a product that ... is a......
  • Bravman v. Baxter Healthcare Corp.
    • United States
    • U.S. District Court — Southern District of New York
    • January 24, 1994
    ...law. Bravman v. Baxter Healthcare Corp., 794 F.Supp. 96 (S.D.N.Y.1992) ("Bravman I"), aff'd in part and rev'd in part, remanded, 984 F.2d 71 (2d Cir. 1993). On appeal, the Second Circuit affirmed in part and reversed in part. Bravman v. Baxter Healthcare Corp., 984 F.2d 71 (2d Cir. 1993). T......
  • Rico v. Ducart
    • United States
    • U.S. Court of Appeals — Ninth Circuit
    • November 20, 2020
    ...or preventing [plaintiff's] sleep," stated a Due Process or Eighth Amendment claim); see generally Bravman v. Baxter Healthcare Corp. , 984 F.2d 71, 75 n.3 (2d Cir. 1993) ("The gravity of the harm from noises that disturb a person's sleep, for example, is ordinarily much greater when the no......
  • Request a trial to view additional results
3 books & journal articles
  • Renewed look at the duty to warn and affirmative defenses.
    • United States
    • Defense Counsel Journal Vol. 61 No. 2, April 1994
    • April 1, 1994
    ...Cir. 1982). (36.) Voss v. Black & Decker Mfg. Co., 450 N.E.2d 204, 208 (N.Y. 1983). See, e.g., Bravman v. Baxter Healthcare Corp., 984 F.2d 71 (2d Cir. 1993); Macrie v. SDS Biotech Corp., 630 A.2d 805, 810-11 (N.J. Super. 1993). (37.) See Jimenez v. Dreis & Krump Mfg. Co., 736 F.2d ......
  • Design defects.
    • United States
    • Missouri Law Review Vol. 73 No. 2, March - March 2008
    • March 22, 2008
    ...litigation is treated in DAVID G. OWEN, PRODUCTS LIABILITY LAW ch. 17 (2d ed. 2008). (14.) See, e.g., Bravman v. Baxter Healthcare Corp., 984 F.2d 71 (2d Cir. 1993) (N.Y. law) (noisy mechanical heart valve); Toner v. Lederle Labs., 828 F.2d 510 (9th Cir. 1987) (Idaho law) (DPT vaccine shoul......
  • Combatting fear of future injury and medical monitoring claims.
    • United States
    • Defense Counsel Journal Vol. 61 No. 4, October 1994
    • October 1, 1994
    ...569 (Cal.App. 1993). (30.) 794 F.Supp. 96 (S.D.N.Y. 1992). (31.) 457 N.E.2d 1150, 1155 (N.Y. 1983). (32.) 794 F.Supp. at 101. (33.) 984 F.2d 71 (2d Cir. 1991). (34.) 929 F.2d 1094 (5th Cir. 1991). (35.) Id. at 1099-1100. (36.) Id. at 1100. (37.) 266 Cal.Rptr. 106 (Cal.App. 1990). (38.) W. P......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT